38688962|t|Oxyresveratrol-beta-cyclodextrin mitigates streptozotocin-induced Alzheimer's model cognitive impairment, histone deacetylase activity in rats: in silico & in vivo studies.
38688962|a|Alzheimer's disease (AD) is associated with cognitive deficits and epigenetic deacetylation that can be modulated by natural products. The role of natural oxyresveratrol-beta-cyclodextrin (ORV) on cognition and histone deacetylase activity in AD is unclear. Herein, in-silico docking and molecular dynamics simulation analysis determined that oxyresveratrol potentially targets histone deacetylase-2 (HDAC2). We therefore evaluated the in vivo ameliorative effect of ORV against cognitive deficit, cerebral and hippocampal expression of HDAC in experimental AD rats. Intracerebroventricular injection of STZ (3 mg/kg) induced experimental AD and the rats were treated with low dose (200 mg/kg), high dose (400 mg/kg) of ORV and donepezil (10 mg/kg) for 21 days. The STZ-induced AD caused cognitive and behavioural deficits demonstrated by considerable increases in acetylcholinesterase activity and escape latency compared to sham control. The levels of malondialdehyde (MDA) and HDAC activity were significantly increased in AD disease group comparison to the sham. Interestingly, the ORV reversed the cognitive-behavioural deficit and prominently reduced the MDA and HDAC levels comparable to the effect of the standard drug, donepezil. The findings suggest anti-AD role of ORV via antioxidant effect and inhibition of HDAC in the hippocampal and frontal cortical area of rats for AD.
38688962	0	32	Oxyresveratrol-beta-cyclodextrin	Chemical	-
38688962	43	57	streptozotocin	Chemical	MESH:D013311
38688962	66	77	Alzheimer's	Disease	MESH:D000544
38688962	84	104	cognitive impairment	Disease	MESH:D003072
38688962	138	142	rats	Species	10116
38688962	173	192	Alzheimer's disease	Disease	MESH:D000544
38688962	194	196	AD	Disease	MESH:D000544
38688962	217	235	cognitive deficits	Disease	MESH:D003072
38688962	328	360	oxyresveratrol-beta-cyclodextrin	Chemical	-
38688962	362	365	ORV	Chemical	-
38688962	416	418	AD	Disease	MESH:D000544
38688962	516	530	oxyresveratrol	Chemical	MESH:C034912
38688962	551	572	histone deacetylase-2	Gene	3066
38688962	574	579	HDAC2	Gene	3066
38688962	640	643	ORV	Chemical	-
38688962	652	669	cognitive deficit	Disease	MESH:D003072
38688962	710	714	HDAC	Gene	9734
38688962	731	733	AD	Disease	MESH:D000544
38688962	734	738	rats	Species	10116
38688962	777	780	STZ	Chemical	MESH:D013311
38688962	812	814	AD	Disease	MESH:D000544
38688962	823	827	rats	Species	10116
38688962	893	896	ORV	Chemical	-
38688962	901	910	donepezil	Chemical	MESH:D000077265
38688962	939	942	STZ	Chemical	MESH:D013311
38688962	951	953	AD	Disease	MESH:D000544
38688962	961	995	cognitive and behavioural deficits	Disease	MESH:D003072
38688962	1038	1058	acetylcholinesterase	Gene	43
38688962	1127	1142	malondialdehyde	Chemical	MESH:D008315
38688962	1144	1147	MDA	Chemical	MESH:D008315
38688962	1153	1157	HDAC	Gene	9734
38688962	1199	1201	AD	Disease	MESH:D000544
38688962	1259	1262	ORV	Chemical	-
38688962	1276	1305	cognitive-behavioural deficit	Disease	MESH:D003072
38688962	1334	1337	MDA	Chemical	MESH:D008315
38688962	1342	1346	HDAC	Gene	9734
38688962	1401	1410	donepezil	Chemical	MESH:D000077265
38688962	1438	1440	AD	Disease	MESH:D000544
38688962	1449	1452	ORV	Chemical	-
38688962	1494	1498	HDAC	Gene	9734
38688962	1547	1551	rats	Species	10116
38688962	1556	1558	AD	Disease	MESH:D000544
38688962	Positive_Correlation	MESH:D013311	MESH:D000544
38688962	Association	MESH:C034912	3066
38688962	Positive_Correlation	MESH:D013311	43
38688962	Negative_Correlation	MESH:D000077265	MESH:D008315
38688962	Positive_Correlation	MESH:D003072	43
38688962	Positive_Correlation	MESH:D008315	MESH:D000544
38688962	Positive_Correlation	MESH:D000544	9734
38688962	Positive_Correlation	MESH:D000544	43
38688962	Positive_Correlation	MESH:D013311	MESH:D003072

